🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Stacy D. D’Andre

ORCID: 0000-0003-4726-7223

Also affiliated with Sutter Medical Center, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.”.

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6003

N/A

0.606DataRank · unranked

56 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +15 more

Weight-centric prevention of cancer

Obesity Pillars(2024)10.1016/j.obpill.2024.100106

N/A

0DataRank · unranked

4 citations

Andrés Acosta, Elizabeth Cathcart-Rake, Stacy D. D’Andre, Maria D. Hurtado, Diego Añazco

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors

Journal of Pain and Symptom Management(2025)10.1016/j.jpainsymman.2025.04.016

N/A

0DataRank · unranked

2 citations

Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J. Ruddy, Jacob J. Orme +14 more